Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 19

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 19
---
 consulting, advisory or other compensatory fee from the Company other than their director compensation, and that none have any affiliate relationships with the Company or other relationships that would impair the director’s judgment as a member of the Compensation Committee. Board Committees The following table sets forth the current members of the Audit, Compensation and Governance Committees of the Board:

| Name                                         |     | Audit |     | Compensation |     | Governance |
| Craig Collard                                |     |       |     |              |     |            |
| Sharmila Dissanaike, M.D., FACS, FCCM        |     |       |     | C            |     | X          |
| Craig Johnson                                |     | C     |     | X            |     |            |
| Michael Kaseta                               |     | X     |     |              |     |            |
| Adam Morgan                                  |     |       |     |              |     |            |
| Susan Rodriguez                              |     |       |     | X            |     | X          |
| Christian Waage                              |     | X     |     |              |     | C          |
| C: Chair of Committee X: Member of Committee |     |       |     |              |     |            |

13

Audit Committee.The Audit Committee is composed of three directors: Messrs. Johnson, Kaseta, and Waage. Mr. Johnson serves as the Chair of the Audit Committee. The Audit Committee is responsible for appointing, overseeing and replacing, if necessary, our independent registered public accounting firm and for evaluating its work. The Audit Committee also assists the Board in overseeing the integrity of our financial statements and accounting and financial reporting processes, compliance with legal and regulatory requirements, the independent registered public accounting firm’s qualifications and independence and the performance of the Company’s independent registered public accounting firm and internal audit function. During 2024, the Audit Committee received written disclosures from and communicated with the independent registered public accounting firm; met with management and the independent registered public accounting firm to discuss our financial statements; met with the independent registered public accounting firm to discuss matters that may affect our financial statements; approved related-party transactions, if any; provided oversight of risk management, including oversight of cybersecurity risks and risks related to environmental, social and governance matters; and approved professional services provided to us by the independent public accountants. The Audit Committee, together with the Board, was also responsible for reviewing our plans for providing appropriate financial resources to sustain our operations, including review of our strategic corporate plan and annual operating budget. The